By Sheri Kasprzak
New York, Dec. 7 - ImmuneRegen Biosciences, Inc. wrapped a $5.5 million private placement.
The company sold 220 units at $25,000 each. Each unit consists of 156,250 shares and warrants for 78,125 shares.
The warrants are exercisable at $0.50 each through Dec. 6, 2011.
Proceeds will be used for product development.
Joseph Stevens & Co., Inc. was the placement agent.
ImmuneRegen, based in Scottsdale, Ariz., is a subsidiary of IR Biosciences Holdings, Inc. and develops treatments for radiation exposure.
| Issuer: | ImmuneRegen Biosciences, Inc.
|
| Issue: | Units of 156,250 shares and warrants for 78,125 shares
|
| Amount: | $5.5 million
|
| Units: | 220
|
| Price: | $25,000
|
| Warrants: | For 78,125 shares per unit
|
| Warrant expiration: | Dec. 6, 2011
|
| Warrant strike price: | $0.50
|
| Placement agent: | Joseph Stevens & Co., Inc.
|
| Settlement date: | Dec. 6
|
| Stock symbol: | OTCBB: IRBO
|
| Stock price: | $0.20 at close Dec. 7
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
